Structural and functional outcomes in animal models of stroke: What do they measure? Malcolm Macleod University of Edinburgh.
Birds, Bears, Turtles, Trains, Coupons, Cocks...and Moses: my talk to AHCJ 2013 Boston
Outline General endpoint considerations Surrogate endpoints Composite endpoints and recurrent events Safety outcomes (adverse events)
What is Screening? Hui Jin Department of Epidemiology and Health Statistics School of Public Health Southeast University.
Thomas B. Newman, MD, MPH Andi Marmor, MD, MSEd October 21, 2010.
Making therapeutic decisions with ongoing drug shortages Dr. Roland Halil, BSc(Hon), BScPharm, ACPR, PharmD Pharmacist, Bruyere Academic Family Health.
Pragmatic Randomised Trials
Statistical Issues in Clinical Studies Using Laboratory Endpoints Elizabeth S. Garrett, PhD Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University.
The Future of Information Security Awareness Kelley Archer: Facilitator - Director Information Security, AIMIA Inc. Aaron Cohen: Managing Partner, MAD.
Grading Strength of Evidence Prepared for: The Agency for Healthcare Research and Quality (AHRQ) Training Modules for Systematic Reviews Methods Guide.
Proteinuria as a surrogate outcome in CKD UKPDS Rudy Bilous Middlesbrough, UK.
Comparative Effectiveness Research: Background, Priorities, Methods
